Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?

Journal of the American Geriatrics Society

Volumn 44, Issue 7, 1996, Pages 865-870

  Birge, Stanley J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIGESTAGEN; CHOLINESTERASE INHIBITOR; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL BENZOATE; ESTROGEN; ESTRONE; GESTAGEN; MIFEPRISTONE; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN; PROGESTERONE; TACRINE;

AGING; ALZHEIMER DISEASE; AMNESIA; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM FUNCTION; CHOLINERGIC NERVE CELL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DRUG POTENTIATION; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MENTAL FUNCTION; NERVE FIBER GROWTH; NONHUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; REVIEW; SEXUAL BEHAVIOR; SYNAPTOGENESIS;

EID: 8944226107     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb03749.x     Document Type: Review

References (79)

1. Khachaturian ZA. Calcium hypothesis of Alzheimer's disease and brain aging in calcium hypothesis of aging and dementia. Ann N Y Acad Sci 1994;747:1-11.
2. Matsumoto A, Arai Y, Osanai M. Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 1985;2:412-418.
3. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult. J Neurosci 1992;12:2549-2554.
4. Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during estrus cycle in the rat. J Comp Neurol 1993;336:293-306.
5. Arimatsu Y, Hatamaka H. Estrogen treatment enhances survival of cultured amygdala neurons in a defined medium. Dev Brain Res 1986;26:151-159.
6. Faivre-Bauman A, Rosenbaum E, Puymirate J et al. Differentiation of fetal mouse hypothalamic cells in serum-free medium. Dev Neurosci 1981;4:118-129.
7. Toran-Allerand CD. On the genesis of sexual differentiation of the central nervous system: Morphogenic consequences of steroidal exposure and possible role of a-fetoprotein. Prog Brain Res 1984;61:63-98.
8. Martin DP, Schmidt RE, DiStefano PS et al. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J Cell Biol 1988;106:829-844.
9. Hefti F, Hartikka J, Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases (review). Neurobiol Aging 1989;10:515-533.
10. Fischer WI, Wictorin K, Bjorklund A et al. Intracerebral infusion of nerve growth factor ameliorates cholinergic neuron atrophy and spatial memory impairments in aged rats. Nature 1987;329:65-68.
11. Toran-Allerand CD, Miranda RC, Bentham WDL et al. Estrogen receptors colocalize with low affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A 1992;89:4668-4672.
12. Sohrabji F, Miranda RC, Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994;14:459-471.
13. Watson MA, Milbrandt J. The NGFI-β gene, a transcriptionally inducible member of the steroid receptor gene superfamily: Genomic structure and expression in rat brain after seizure induction. Mol Cell Biol 1989;9:4213-4219.
14. Singh M, Meyer EM, Simpkins JW. Ovariectomy reduces ChAT activity and NGF mRNA levels in the frontal cortex and hippocampus of the female Sprague-Dawley rats. Neuroscience Abstracts 1993;14:254.
15. Singh M, Meyer EM, Isaackson PJ, Simpkins JW. The effect of ovariectomy and estradiol-replacement on brain derived neurotrophic factor mRNA expression in brain regions of female Sprague-Dawley rats. Endocrinology 1995;136:2320-2324.
16. DiAugustine RP, Petrusy P, Bell GI et al. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology 1988;122:2355-2363.
17. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644:305-312.
18. Regland B, Gottfries CG. The role of amyloid β protein in Alzheimer's disease. Lancet 1992;340:467-469.
19. Sisodia SS, Koo EH, Beyreuther K et al. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 1990;248:492-495.
20. Armstrong RA. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995;6:121-125.
21. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994;269:13065-13068.
22. Sullivan JM, Vander Zwaag R, Hughes JP et al. Estrogen replacement and coronary artery disease effect on survival in postmenopausal women. Arch Intern Med 1990;150:2557-2562.
23. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994;89:2545-2551.
24. Polderman KH, Coen D, Stehouwer A et al. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993;118:429-432.
25. Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methylester, an inhibitor of nitritic oxide synthesis. Am J Obstet Gynecol 1992;16:828-833.
26. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atheroscierotic coronary arteries. Circ Res 1990;81:1680-1687.
27. Ganger KF, Vyas S, Whitehead M et al. Pulsatibility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839-842.
28. Ohkura T, Teshima Y, Isse K et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995;2:13-18.
29. Second symposium on ageing and ageing disorders, Stockholm 1993. Dementia 1994;5:129-213.
30. O'Brien MD. How does cerebrovascular disease cause dementia? Dementia 1994;5:133-136.
31. Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer's disease. Neurobiol Aging 1992;13:483-491.
32. Zhang WW, Badonic T, Höög A et al. Structural and vasoactive factors influencing intracerebral arterioles in cases of vascular dementia and other cerebrovascular disease: A review. Dementia 1994;5:153-162.
33. Ohkura T, Teshima Y, Isse K et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995;2:13-18.
34. Funk JL, Mortel KF, Meyer JS. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 1991;2:268-272.
35. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen therapy and stroke: A prospective study. Br Med J 1988;297:519-522.
36. Falkeborn M, Persson I, Terent A. Hormone replacement therapy and the risk of stroke. Arch Intern Med 1993;153:1201-1209.
37. Hunt K, Vessey M, McPherson R. Mortality in a cohert of long-term users of hormone replacement therapy: An updated analysis. Br J Obstet Gynaecol 1990;97:1080-1086.
38. Bush TL, Barrett-Connor E, Cowan LO et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: Results from the lipid research clinics program follow-up study. Circulation 1987;75:1102-1109.
39. Stampfer MJ, Colditz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. N Eng J Med 1991;325:756-762.
40. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988;14:177-187.
41. Sherwin BB, Gelfand MM. A prospective one-year study of estrogen and progestin in postmenopausal women: Efects on clinical symptoms and lipoprotein lipids. Obstet Gynecol 1989;73:759-766.
42. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-995.
43. Klaibet EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen replacement therapy for severe persistent depressions in women. Arch Gen Psychiatry 1979;36:550-554.
44. Campbell S, Whitehead M. Estrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977;4:31-47.
45. Hackman BW, Gailbraith D. Replacement therapy and piperazine oestrone sulphate ("Harmogen") and its effects on memory. Curr Med Res Opin 1976;4:303-306.
46. Luine VN, McEwen BS. Effect of estradiol on turnover of type H monoamine oxidase in brain. J Neurochem 1977;28:1221-1227.
47. Gonzales GF, Carrillo C. Blood serotonin levels in postmenopausal women: Effects of age and serum oestradiol levels. Maturitas 1993;17:23-29.
48. Magos AL, Brewster E, Singh R et al. The effects of norethisterone in post-menopausal women on estrogen replacement therapy: A model for premenstrual syndrome. Br J Obstet Gynaecol 1986;93:1290-1296.
49. Holst J, Backstrom T, Hammerbach S, Von Shoultz B. Progesterone addiction during estrogen replacement therapy - Effects on vasomotor symptoms and mood. Maturitas 1989;11:13-19.
50. Dennerstein L, Burrows GD, Hyman G, Sharpe K. Hormone therapy and affect. Maturitas 1979;1:247-259.
51. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann N Y Acad Sci 1990;592:474-475.
52. Phillips S, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1991;17:485-495.
53. Rauramo KL, Langerspetz K, Engblom P, Punnonen R. The effect of castration and peroral estrogen therapy on some psychological functions. Front Horm Res 1975;8:133-151.
54. VanHulle R, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in postmenopausal women. In: vanKeep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on Menopausal Research. London: MTP Press, 1976, pp 94-99.
55. Robinson D, Friedman L, Marcus R et al. Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994;42:919-922.
56. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993;260:2637-2641.
57. Molsa PK, Marttila RJ, Rinne UK. Epidemiology of dementia in a Finnish population. Acta Neurol Scand 1982;65:541-552.
58. Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: A quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465-479.
59. Aronson MK, Ooi WL, Morgenstern H et al. Women, myocardial infarction and dementia in the very old. Neurology 1990;40:1102-1106.
60. Graves AB, White E, Koepsell TD et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-774.
61. Meldrum DR, Davidson BJ, Tatryn IV, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981;57:624-628.
62. Berlinger WG, Potter JF. Low body mass index in demented outpatients. J Am Geriatr Soc 1991;39:973-978.
63. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140:256-261.
64. Sunderland T, Merril CR, Harrington MG et al. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 1989;2:570.
65. Rudman D, Shetty KR, Mattson DE. Plasma dehydroepiandrosterone sulphate in nursing home men. J Am Geriatr Soc 1990;38:421-427.
66. Leblhuber F, Windhager E, Steinparz FX et al. Dehydroepiandrosteronesulphate (DHEA-S) serum levels in normal aging and Alzheimer's disease (AD). Age 1991;14:116-118.
67. Sparks DL, Huaichen L, Scheff SW et al. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 1993;52:135-142.
68. Brenner DE, Kukull WA, Storgachis A et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-controlled study. Am J Epidemiol 1994;140:262-267.
69. Herbert LE, Scherr PA, Beckett LA et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995;273:1354-1359.
70. Fillit H, Weinreb H, Cholst I. Observations in a preliminary open trial of estradiol therapy for senile dementia (Alzheimer's type). Psychoneuroendochnology 1986;2:337-345.
71. Honjo H, Ogino Y, Naitoh K et al. In vivo effects by estrone sulfate in the central nervous system - Senile dementia (Alzheimer's type). J Steroid Biochem 1989;34:521-525.
72. Ohkura T, Isse K, AkazawaK et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer's type. Endocrine J 1994;41:361-371.
73. Ohkura T, Isse K, Akazawa K et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: Seven case reports. Dementia 1995;6:99-107.
74. Caldwell BM. An evaluation of psychological effects of sex hormone administration in aged women. J Gerontol 1954;9:168-174.
75. Kantor HI, Michael CM, Shore H. Estrogen for older women. Am J Obstet Gynecol 1973;116:115-118.
76. Schneider LS, Farlow MK, Henderson VW, Pogoda JM. Estrogen replacement therapy may enhance response to tacrine in women with Alzheimer's disease. Neurology 1995;45(suppl):A288.
77. Knapp MJ, Knopman DS, Solomon PR et al. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994;271:985-991.
78. Snowdon DA, Markeshery WR, Mortimer JA. Biologic aging and Alzheimer's disease: Findings from the Nun Study. Gerontologist 34:A246, 1995.
79. Morris JC, Storandt M, McKeel DW et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:702-719.